Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Elife Holdings Limited ( (HK:0223) ) has provided an update.
Elife Holdings Limited has issued a detailed response to China Innovation Investment Limited’s comments on various company documents, centering on governance and directorship disputes that stemmed from a trading suspension in the company’s shares that began in December 2024 at the request of a former board aligned with the Offeror. The company highlights that the former board’s attempts to delay an extraordinary general meeting were ruled by the High Court of Hong Kong to be for improper purposes and void, and stresses that the 12‑month-plus suspension has harmed its supply chain operations, weakened customer confidence, and limited access to funding. Following the removal of the former board in March 2025, the current board says it has focused on meeting regulatory resumption guidance through independent forensic investigation and internal control review, publication of outstanding financial results, and ongoing engagement with regulators, while maintaining core operations and relationships, and it questions the Offeror’s continued challenges to issues it says have already been thoroughly investigated and addressed.
More about Elife Holdings Limited
Elife Holdings Limited, incorporated in the Cayman Islands and listed in Hong Kong, operates a supply chain business whose financial performance and ability to secure new business and funding have been adversely affected by a prolonged suspension of trading in its shares.
Technical Sentiment Signal: Sell
Current Market Cap: HK$147.3M
See more insights into 0223 stock on TipRanks’ Stock Analysis page.